Target intelligence / Profile preview

Various pathogenic antigens

Molecular classification
Other
01

Overview

Various pathogenic antigens is a collective term referring to the diverse array of molecular structures—including proteins, polysaccharides, and lipids—derived from infectious agents such as bacteria, viruses, fungi, and parasites (PMC6111618, PMC5821153). These antigens are the primary targets of the host's adaptive immune system, where they are recognized by B-cell receptors (antibodies) and T-cell receptors to initiate a protective response (PubMed 22174415). In clinical pharmacology, this term is frequently used to describe the broad spectrum of targets for polyvalent therapies like Intravenous Immunoglobulin (IVIG) or broad-spectrum vaccines (DrugBank DB00028). These therapeutic agents work by either providing pre-formed antibodies (passive immunity) or stimulating the production of new antibodies (active immunity) that neutralize toxins, block pathogen entry into host cells, and facilitate the destruction of microbes through opsonization and complement activation (PMC5821153). Additionally, these antigens are utilized in diagnostic assays to detect the presence of specific infections or to monitor the efficacy of immunization (PMC5821153). Because the term encompasses thousands of distinct molecular entities across numerous species, it is considered a categorical designation rather than a specific molecular target (PMC6111618).

Other names
Microbial antigensPathogen-derived antigensInfectious agent antigensPathogen-associated molecular patternsExo-antigensEndo-antigens
02

Mechanism of action

Binding and neutralization of diverse microbial components to prevent infection, block host cell entry, and promote opsonization and clearance by the immune system.

03

Biological functions

Immune responseInfectionPathogenesisCell entryToxin production
04

Disease associations

Infection
05

Safety considerations

AnaphylaxisInfusion reactionsAntibody-dependent enhancementRisk of pathogen transmissionAseptic meningitisRenal failure
06

Interacting drugs

Immune Globulin Intravenous

6 more in the full profile.

07

Biomarkers

Antibody titersPathogen loadC-reactive proteinSerum IgG levelsNeutralizing antibody titers

Beyond the preview

Go deeper on Various pathogenic antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Various pathogenic antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call